![]() ![]() ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Application filed by ModernaTx Inc filed Critical ModernaTx Inc Priority to US16/005,286 priority Critical patent/US10266485B2/en Assigned to MODERNATX, INC. Original Assignee ModernaTx Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Benenato Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number US16/005,286 Other versions US20180273467A1 Google Patents Compounds and compositions for intracellular delivery of therapeutic agentsÄownload PDF Info Publication number US10266485B2 US10266485B2 US16/005,286 US201816005286A US10266485B2 US 10266485 B2 US10266485 B2 US 10266485B2 US 201816005286 A US201816005286 A US 201816005286A US 10266485 B2 US10266485 B2 US 10266485B2 Authority US United States Prior art keywords alkyl nanoparticle composition group glycero therapeutic Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US10266485B2 - Compounds and compositions for intracellular delivery of therapeutic agents US10266485B2 - Compounds and compositions for intracellular delivery of therapeutic agents ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |